Accumulation of losses of heterozygosity and multistep carcinogenesis in pulmonary adenocarcinoma.
暂无分享,去创建一个
T. Oda | Y. Aoyagi | Atsushi Ochiai | M. Noguchi | A. Ochiai | T. Iijima | Y. Morishita | T. Yokose | Y. Minami | T Yokose | A Ochiai | Y Aoyagi | Y Minami | T Iijima | Y Morishita | T Oda | K Fukao | M Noguchi | K. Fukao | Y. Morishita | Tatsuya Oda | K. Fukao
[1] M. Noguchi,et al. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. , 2000, Cancer research.
[2] S. Lam,et al. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. , 2000, Cancer research.
[3] S. Hirohashi,et al. Comparative allelotype of early and advanced stage non‐small cell lung carcinomas , 1996, Genes, chromosomes & cancer.
[4] J. Minna,et al. Multiple clonal abnormalities in the bronchial epithelium of patients with lung cancer. , 1999, Journal of the National Cancer Institute.
[5] Setsuo Hirohashi,et al. Small adenocarcinoma of the lung. Histologic characteristics and prognosis , 1995 .
[6] Y. Ishikawa,et al. Association of Loss of Heterozygosity at the p53 Locus with Chemoresistance in Osteosarcomas , 1998, Japanese journal of cancer research : Gann.
[7] W. Stolz,et al. Assessment of microsatellite instability and loss of heterozygosity in sporadic keratoacanthomas , 1999, Archives of Dermatological Research.
[8] M. Noguchi,et al. Application of the p53 and K‐ras gene mutation patterns for cytologic diagnosis of recurrent lung carcinomas , 2000, Cancer.
[9] Y. Shimosato. [Histological Typing of Lung and Pleural Tumors (3rd edition, 1999): Malignant epithelial tumors]. , 2002, Nihon rinsho. Japanese journal of clinical medicine.
[10] S. Hirohashi,et al. A novel tumor suppressor locus on chromosome 18q involved in the development of human lung cancer. , 1998, Cancer research.
[11] Peter A. Jones,et al. Early acquisition of homozygous deletions of p16/p19 during squamous cell carcinogenesis and genetic mosaicism in bladder cancer , 1998, Oncogene.
[12] J. Minna,et al. Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma , 1999, Oncogene.
[13] C. Croce,et al. The FHIT Gene, Spanning the Chromosome 3p14.2 Fragile Site and Renal Carcinoma–Associated t(3;8) Breakpoint, Is Abnormal in Digestive Tract Cancers , 1996, Cell.
[14] 中山 治彦. Clonal growth of atypical adenomatous hyperplasia of the lung : cytofluorometric analysis of nuclear DNA content , 1993 .
[15] J. Jen,et al. Detailed deletion mapping at chromosome 9p21 in non‐small cell lung cancer by microsatellite analysis and fluorescence in situ hybridization , 1997, International journal of cancer.
[16] R. Rosell,et al. Microsatellite alterations at 5q21, 11p13, and 11p15.5 do not predict survival in non-small cell lung cancer. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[17] 穴見 洋一. Amplotyping of microdissected, methanol-fixed lung carcinoma by arbitrarily primed polymerase chain reaction , 2000 .